Bostongene

Bostongene company information, Employees & Contact Information

Explore related pages

Related company profiles:

BostonGene helps drug developers de-risk and accelerate research and development using a clinically validated AI platform purpose-built for oncology and supported by a CLIA-certified and CAP-accredited clinical laboratory. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights that inform trial design, optimize patient selection and improve clinical outcomes. Our diagnostic and treatment recommendation solutions are used in clinical settings to personalize care and guide therapy decisions for patients.
Looking for a particular Bostongene employee's phone or email?

Bostongene Questions

News

BostonGene to Present Omnimodal Foundation AI for Cancer and the Immune System at SITC 2025 Annual Meeting - Yahoo Finance

BostonGene to Present Omnimodal Foundation AI for Cancer and the Immune System at SITC 2025 Annual Meeting Yahoo Finance

BostonGene to Highlight Omnimodal AI Innovations for Precision Oncology at the 21st Annual Precision Oncology & RadMed Symposium - The AI Journal

BostonGene to Highlight Omnimodal AI Innovations for Precision Oncology at the 21st Annual Precision Oncology & RadMed Symposium The AI Journal

BostonGene Announces Collaboration with SWOG Cancer Research Network to Drive Personalized Approaches - Business Wire

BostonGene Announces Collaboration with SWOG Cancer Research Network to Drive Personalized Approaches Business Wire

BostonGene Showcases AI-Powered Multimodal Analytics at ESMO Congress 2025 to Advance Cancer Researc - PharmiWeb.com

BostonGene Showcases AI-Powered Multimodal Analytics at ESMO Congress 2025 to Advance Cancer Researc PharmiWeb.com

BostonGene Honored with Five 2025 Stevie® Awards for Technology Excellence - Yahoo Finance

BostonGene Honored with Five 2025 Stevie® Awards for Technology Excellence Yahoo Finance

BostonGene Appoints Dr. Ferran Prat as Chief Commercial Officer - citybiz

BostonGene Appoints Dr. Ferran Prat as Chief Commercial Officer citybiz

BostonGene's Precision Oncology Breakthroughs: AI-Enhanced Multi-omics and Digital Pathology - Pharmaceutical Technology

BostonGene's Precision Oncology Breakthroughs: AI-Enhanced Multi-omics and Digital Pathology Pharmaceutical Technology

Clinical Trials Arena Excellence Awards 2024: BostonGene - Clinical Trials Arena

Clinical Trials Arena Excellence Awards 2024: BostonGene Clinical Trials Arena

Study Published in Cell Reports Medicine Showcases BostonGene’s Multimodal AI Solutions to Stratify PD-1 and VEGF Immunotherapy Outcomes in Kidney Cancer - Yahoo Finance

Study Published in Cell Reports Medicine Showcases BostonGene’s Multimodal AI Solutions to Stratify PD-1 and VEGF Immunotherapy Outcomes in Kidney Cancer Yahoo Finance

Transgene, NEC, and BostonGene Expand Trial of Neoantigen Cancer Vaccine TG4050: Press Releases - NEC Global

Transgene, NEC, and BostonGene Expand Trial of Neoantigen Cancer Vaccine TG4050: Press Releases NEC Global

MD Anderson and BostonGene announce strategic alliance to advance personalized cancer diagnostics and treatments - MD Anderson Cancer Center

MD Anderson and BostonGene announce strategic alliance to advance personalized cancer diagnostics and treatments MD Anderson Cancer Center

Joe Lennerz was appointed as the Chief Scientific Officer at BostonGene - Oncodaily

Joe Lennerz was appointed as the Chief Scientific Officer at BostonGene Oncodaily

USD School of Law Alumnus Ferran Prat ʼ07 (JD) Appointed Chief Commercial Officer at BostonGene - University of San Diego

USD School of Law Alumnus Ferran Prat ʼ07 (JD) Appointed Chief Commercial Officer at BostonGene University of San Diego

Clinical Trials Arena Excellence Awards 2023: BostonGene - Clinical Trials Arena

Clinical Trials Arena Excellence Awards 2023: BostonGene Clinical Trials Arena

BostonGene, NEC and JIP Form Joint Venture in Japan: Press Releases - NEC Global

BostonGene, NEC and JIP Form Joint Venture in Japan: Press Releases NEC Global

BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients - Business Wire

BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients Business Wire

MD Anderson licenses EGFR classification system for lung cancer - MD Anderson Cancer Center

MD Anderson licenses EGFR classification system for lung cancer MD Anderson Cancer Center

BostonGene Announces $150 Million Series B Funding: Press Releases - NEC Global

BostonGene Announces $150 Million Series B Funding: Press Releases NEC Global

LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial - Business Wire

LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial Business Wire

DeSide: A unified deep learning approach for cellular deconvolution of tumor microenvironment - PNAS

DeSide: A unified deep learning approach for cellular deconvolution of tumor microenvironment PNAS

BostonGene Named a Fierce Life Sciences Innovation Awards Winner in the AI Innovation Category - BioSpace

BostonGene Named a Fierce Life Sciences Innovation Awards Winner in the AI Innovation Category BioSpace

BostonGene Named Akoya Biosciences’ Qualified CRO - Contract Pharma

BostonGene Named Akoya Biosciences’ Qualified CRO Contract Pharma

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy - ScienceDirect.com

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy ScienceDirect.com

Transcriptional phenocopies of deleterious KEAP1 mutations dictate survival outcomes in lung cancer treated with immunotherapy - medRxiv

Transcriptional phenocopies of deleterious KEAP1 mutations dictate survival outcomes in lung cancer treated with immunotherapy medRxiv

Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data - Nature

Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data Nature

Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer - ScienceDirect.com

Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer ScienceDirect.com

Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes - ScienceDirect.com

Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes ScienceDirect.com

Multiregional single-cell proteogenomic analysis of ccRCC reveals cytokine drivers of intratumor spatial heterogeneity - ScienceDirect.com

Multiregional single-cell proteogenomic analysis of ccRCC reveals cytokine drivers of intratumor spatial heterogeneity ScienceDirect.com

MWC Keynote Speech by President Morita: Empowering a data-driven future with AI - NEC Global

MWC Keynote Speech by President Morita: Empowering a data-driven future with AI NEC Global

A rebirth in Boston: Gene therapy turns 10 - Boston Children's Answers

A rebirth in Boston: Gene therapy turns 10 Boston Children's Answers

Here are the 16 healthcare companies to hit $1 billion valuations this year as the market stumbles - businessinsider.com

Here are the 16 healthcare companies to hit $1 billion valuations this year as the market stumbles businessinsider.com

Japan's NEC forges clinical development of Neoantigen Cancer Vaccine - BioSpectrum Asia

Japan's NEC forges clinical development of Neoantigen Cancer Vaccine BioSpectrum Asia

3 Companies Join Forces to Test Personalized ‘Teaching’ Vaccine for Ovarian Cancer - Ovarian Cancer News Today

3 Companies Join Forces to Test Personalized ‘Teaching’ Vaccine for Ovarian Cancer Ovarian Cancer News Today

Famous American company BostonGene is already in Armenia - 1Lurer

Famous American company BostonGene is already in Armenia 1Lurer

Armenian Healthcare Ministry, Netcracker/BostonGene companies discuss cooperation - Armenpress

Armenian Healthcare Ministry, Netcracker/BostonGene companies discuss cooperation Armenpress

Global Digital Biomarkers Market Set to Grow at ~17% CAGR by 2032 | DelveInsight - The Globe and Mail

Global Digital Biomarkers Market Set to Grow at ~17% CAGR by 2032 | DelveInsight The Globe and Mail

Top Bostongene Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant